These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9605546

  • 21. Structure-function relationships in the catalytic and starch binding domains of glucoamylase.
    Coutinho PM, Reilly PJ.
    Protein Eng; 1994 Mar; 7(3):393-400. PubMed ID: 8177888
    [Abstract] [Full Text] [Related]

  • 22. Some details of the reaction mechanism of glucoamylase from Aspergillus niger--kinetic and structural studies on Trp52-->Phe and Trp317-->Phe mutants.
    Christensen T, Stoffer BB, Svensson B, Christensen U.
    Eur J Biochem; 1997 Dec 15; 250(3):638-45. PubMed ID: 9461285
    [Abstract] [Full Text] [Related]

  • 23. Improving operating performance of glucoamylase by mutagenesis.
    Ford C.
    Curr Opin Biotechnol; 1999 Aug 15; 10(4):353-7. PubMed ID: 10449316
    [Abstract] [Full Text] [Related]

  • 24. Site-directed mutagenesis of the catalytic base glutamic acid 400 in glucoamylase from Aspergillus niger and of tyrosine 48 and glutamine 401, both hydrogen-bonded to the gamma-carboxylate group of glutamic acid 400.
    Frandsen TP, Dupont C, Lehmbeck J, Stoffer B, Sierks MR, Honzatko RB, Svensson B.
    Biochemistry; 1994 Nov 22; 33(46):13808-16. PubMed ID: 7947792
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of replacing helical glycine residues with alanines on reversible and irreversible stability and production of Aspergillus awamori glucoamylase.
    Chen HM, Li Y, Panda T, Buehler FU, Ford C, Reilly PJ.
    Protein Eng; 1996 Jun 22; 9(6):499-505. PubMed ID: 8862550
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Substitution of asparagine residues in Aspergillus awamori glucoamylase by site-directed mutagenesis to eliminate N-glycosylation and inactivation by deamidation.
    Chen HM, Ford C, Reilly PJ.
    Biochem J; 1994 Jul 01; 301 ( Pt 1)(Pt 1):275-81. PubMed ID: 8037681
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Reaction mechanisms of Trp120-->Phe and wild-type glucoamylases from Aspergillus niger. Interactions with maltooligodextrins and acarbose.
    Olsen K, Christensen U, Sierks MR, Svensson B.
    Biochemistry; 1993 Sep 21; 32(37):9686-93. PubMed ID: 8373772
    [Abstract] [Full Text] [Related]

  • 35. Stopped-flow fluorescence and steady-state kinetic studies of ligand-binding reactions of glucoamylase from Aspergillus niger.
    Olsen K, Svensson B, Christensen U.
    Eur J Biochem; 1992 Oct 15; 209(2):777-84. PubMed ID: 1425682
    [Abstract] [Full Text] [Related]

  • 36. Roles of the aromatic side chains in the binding of substrates, inhibitors, and cyclomalto-oligosaccharides to the glucoamylase from Aspergillus niger probed by perturbation difference spectroscopy, chemical modification, and mutagenesis.
    Svensson B, Sierks MR.
    Carbohydr Res; 1992 Apr 06; 227():29-44. PubMed ID: 1499029
    [Abstract] [Full Text] [Related]

  • 37. Physicochemical characterisation of the two active site mutants Trp(52)-->Phe and Asp(55)-->Val of glucoamylase from Aspergillus niger.
    Christensen T, Frandsen TP, Kaarsholm NC, Svensson B, Sigurskjold BW.
    Biochim Biophys Acta; 2002 Dec 16; 1601(2):163-71. PubMed ID: 12445478
    [Abstract] [Full Text] [Related]

  • 38. Purification and biochemical characterization of a novel mesophilic glucoamylase from Aspergillus tritici WZ99.
    Xian L, Feng JX.
    Int J Biol Macromol; 2018 Feb 16; 107(Pt A):1122-1130. PubMed ID: 28951303
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.